Menu

Announcements

FDA Updates Information for HCT/P Establishments Regarding the COVID-19 Pandemic

The U.S. Food and Drug Administration (FDA) has issued updated information for facilities and medical professionals handling human cell, tissue, or cellular or tissue-based products (HCT/P) with regard to the COVID-19 pandemic, and now, the COVID-19 vaccines. The FDA emphasizes that there have been no reported cases of transmission of COVID-19 via human cell, tissue, or cellular, or tissue-based products.

Scam Alert!

ASRM does not distribute for sale any meeting attendee lists.  Solicitations sent out offering such lists for sale are a scam.

ASRM Task Force on Diversity, Equity and Inclusion Issues Statement, Recommendations

ASRM is passionately committed to promoting diversity within both our membership and leadership, as well as to promoting access to quality reproductive care for all patients without regard to marital status, gender identification, religious beliefs, or race/ethnicity. We are committed to addressing the factors that impact health disparities in our subspecialty and to addressing the ability of individuals to access proper and equal medical care, which is a pervasive barrier to educational, economic, and social success.

ReproductiveFacts.org
is a patient education website of ASRM.
 

RFSubscribe.jpg